Rossignol DA - Search Results

1

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.

Rose S, Niyazov DM, Rossignol DA, Goldenthal M, Kahler SG, Frye RE. Rose S, et al. Among authors: rossignol da. Mol Diagn Ther. 2018 Oct;22(5):571-593. doi: 10.1007/s40291-018-0352-x. Mol Diagn Ther. 2018. PMID: 30039193 Free PMC article. Review.

2

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Rossignol DA, Frye RE. Rossignol DA, et al. Mol Psychiatry. 2012 Mar;17(3):290-314. doi: 10.1038/mp.2010.136. Epub 2011 Jan 25. Mol Psychiatry. 2012. PMID: 21263444 Free PMC article. Review.

3

Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Frye RE, Rossignol DA. Frye RE, et al. Among authors: rossignol da. Pediatr Res. 2011 May;69(5 Pt 2):41R-7R. doi: 10.1203/PDR.0b013e318212f16b. Pediatr Res. 2011. PMID: 21289536 Free PMC article. Review.

4

Melatonin in autism spectrum disorders: a systematic review and meta-analysis.

Rossignol DA, Frye RE. Rossignol DA, et al. Dev Med Child Neurol. 2011 Sep;53(9):783-792. doi: 10.1111/j.1469-8749.2011.03980.x. Epub 2011 Apr 19. Dev Med Child Neurol. 2011. PMID: 21518346 Free article. Review.

5

Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy.

Rossignol DA, Frye RE. Rossignol DA, et al. J Autism Dev Disord. 2012 Apr;42(4):640-2; author reply 643-6. doi: 10.1007/s10803-011-1276-z. J Autism Dev Disord. 2012. PMID: 21556966 No abstract available.

6

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.

Rossignol DA, Frye RE. Rossignol DA, et al. Mol Psychiatry. 2012 Apr;17(4):389-401. doi: 10.1038/mp.2011.165. Epub 2011 Dec 6. Mol Psychiatry. 2012. PMID: 22143005 Free PMC article. Review.

7

Cerebral folate receptor autoantibodies in autism spectrum disorder.

Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Frye RE, et al. Among authors: rossignol da. Mol Psychiatry. 2013 Mar;18(3):369-81. doi: 10.1038/mp.2011.175. Epub 2012 Jan 10. Mol Psychiatry. 2013. PMID: 22230883 Free PMC article. Clinical Trial.

8

Hyperbaric oxygen treatment in autism spectrum disorders.

Rossignol DA, Bradstreet JJ, Van Dyke K, Schneider C, Freedenfeld SH, O'Hara N, Cave S, Buckley JA, Mumper EA, Frye RE. Rossignol DA, et al. Med Gas Res. 2012 Jun 15;2(1):16. doi: 10.1186/2045-9912-2-16. Med Gas Res. 2012. PMID: 22703610 Free PMC article.

9

Melatonin in autism spectrum disorders.

Rossignol DA, Frye RE. Rossignol DA, et al. Curr Clin Pharmacol. 2014;9(4):326-34. doi: 10.2174/15748847113086660072. Curr Clin Pharmacol. 2014. PMID: 24050742 Review.

10

A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Frye RE, Rossignol D, Casanova MF, Brown GL, Martin V, Edelson S, Coben R, Lewine J, Slattery JC, Lau C, Hardy P, Fatemi SH, Folsom TD, Macfabe D, Adams JB. Frye RE, et al. Front Public Health. 2013 Sep 13;1:31. doi: 10.3389/fpubh.2013.00031. Front Public Health. 2013. PMID: 24350200 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page